NEWS
Ovarian Cancer Study Raises Questions about Developing Markers for Early Detection
| A long-awaited assessment of potential biomarkers for detecting early ovarian cancer shows that blood levels of the CA-125 protein remain the best predictor of the disease. But if there is to be any hope that screening will reduce deaths from this disease, then more accurate markers would have to be developed, researchers concluded in the March Cancer Prevention Research. Read more > > |  |
Surgical Biopsy Is Overused for Evaluating Suspicious Breast Imaging Findings
Less invasive needle biopsies have high accuracy, fewer complications, and cost lessAdding Radiation to Chemotherapy Improves Outcomes in Early-Stage Hodgkin Lymphoma
Risk of relapse fell and overall survival improved, but questions remain about late side effectsTrastuzumab after Chemotherapy Is Effective in HER2-Positive Breast Cancer
Disease-free survival benefit is maintained after 4 years of follow-upDenosumab Reduces Risk of Bone Side Effects in Advanced Prostate Cancer
Drug offers modest improvement over current standard of care in phase III trialHigh Rates of Human Papillomavirus Infection Found in Men
Half of the participants in a cohort study were infected with the virus
COMMENTARY
Reenergizing the Agenda for Cancer Communication
by Drs. Galen Cole, Barbara Powe, and Brad Hesse
| Communication experts from the American Cancer Society, Centers for Disease Control and Prevention, and NCI discuss how to take advantage of new communication platforms to make progress against cancer. Read more > > |  |
IN DEPTH
PSA Velocity Does Not Improve Prostate Cancer Detection
Biopsies based strictly on increased PSA levels would lead to many unnecessary procedures
The Epithelial-Mesenchymal Transition in Cancer: A Potentially Fatal Transformation?
The cellular transformation may be a key step in cancer metastasis and recurrence
Featured Clinical Trial: Optimizing Adjuvant Therapy for Resected Pancreatic Cancer
Will combining adjuvant therapies improve survival in pancreatic cancer patients?
Radically Reducing Radiation Exposure during Routine Medical Imaging
Summit jump starts effort to reduce radiation dose from computed tomography
UPDATES
Legislative Update
- Early Actions by the 112th Congress
Notes
- President Appoints New Members to the National Cancer Advisory Board
- Greenwald Named NCI Associate Director for Prevention
- NCI Launches Interactive Cancer Control Community of Practice
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.
